Treatment of Progressive Nodular Histiocytosis With Baricitinib

JAMA Dermatol. 2022 Mar 1;158(3):325-327. doi: 10.1001/jamadermatol.2021.5579.
No abstract available

MeSH terms

  • Azetidines* / therapeutic use
  • Histiocytosis* / diagnosis
  • Histiocytosis* / drug therapy
  • Humans
  • Purines / therapeutic use
  • Pyrazoles / therapeutic use
  • Sulfonamides

Substances

  • Azetidines
  • Purines
  • Pyrazoles
  • Sulfonamides
  • baricitinib